Compass Therapeutics Stock Price on July 27, 2023
| CMPX Stock | USD 1.78 0.13 7.88% |
Below is the normalized historical share price chart for Compass Therapeutics extending back to September 16, 1988. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Compass Therapeutics stands at 1.78, as last reported on the 11th of December 2024, with the highest price reaching 1.78 and the lowest price hitting 1.65 during the day.
If you're considering investing in Compass Stock, it is important to understand the factors that can impact its price. Compass Therapeutics appears to be risky, given 3 months investment horizon. Compass Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0708, which signifies that the company had a 0.0708% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Compass Therapeutics, which you can use to evaluate the volatility of the firm. Please makes use of Compass Therapeutics' Downside Deviation of 4.68, risk adjusted performance of 0.0513, and Mean Deviation of 3.67 to double-check if our risk estimates are consistent with your expectations.
Total Stockholder Equity is likely to rise to about 156 M in 2024, whereas Common Stock Total Equity is likely to drop slightly above 11.1 K in 2024. . At this time, Compass Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 1.40 in 2024, whereas Price Earnings Ratio is likely to drop (4.90) in 2024. Compass Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 5th of April 2021 | 200 Day MA 1.5191 | 50 Day MA 1.7164 | Beta 0.746 |
Compass |
Sharpe Ratio = 0.0708
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CMPX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.8 actual daily | 42 58% of assets are more volatile |
Expected Return
| 0.34 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average Compass Therapeutics is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Compass Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.6503 | Enterprise Value Ebitda (8.92) | Price Sales 267.0845 | Shares Float 88.6 M | Wall Street Target Price 8 |
Related Headline
Nuvectis Pharma Headline on 27th of July 2023
Purchase by Mosseri Marlio Charles of 10000 shares of Nuvect... by Mosseri Marlio Charles
Filed transaction by Nuvectis Pharma Inc executive. General open market or private purchase of non-derivative or derivative security
Compass Therapeutics Valuation on July 27, 2023
It is possible to determine the worth of Compass Therapeutics on a given historical date. On July 27, 2023 Compass was worth 2.57 at the beginning of the trading date compared to the closed value of 2.49. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Compass Therapeutics stock. Still, in general, we apply an absolute valuation method to find Compass Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Compass Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Compass Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 2.52 | 2.59 | 2.51 | 2.56 | 204,784 | |
07/27/2023 | 2.57 | 2.57 | 2.47 | 2.49 | 247,055 |
| 2.50 | 2.69 | 2.50 | 2.67 | 343,777 |
| Backtest Compass Therapeutics | | | Compass Therapeutics History | | | Compass Therapeutics Valuation | Previous | Next |
Compass Therapeutics Trading Date Momentum on July 27, 2023
| On July 28 2023 Compass Therapeutics was traded for 2.67 at the closing time. The top price for the day was 2.69 and the lowest listed price was 2.50 . The trading volume for the day was 343.8 K. The trading history from July 28, 2023 was a factor to the next trading day price jump. The overall trading delta against the next closing price was 7.23% . The overall trading delta against the current closing price is 6.02% . |
Compass Therapeutics Fundamentals Correlations and Trends
By evaluating Compass Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Compass Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Compass financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Compass Therapeutics Stock history
Compass Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Compass is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Compass Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Compass Therapeutics stock prices may prove useful in developing a viable investing in Compass Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 127 M | 78.8 M | |
| Net Loss | -35.3 M | -37.1 M |
Compass Therapeutics Quarterly Net Working Capital |
|
Compass Therapeutics Stock Technical Analysis
Compass Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Compass Therapeutics Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Compass Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Compass Therapeutics December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Compass Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Compass Therapeutics shares will generate the highest return on investment. By undertsting and applying Compass Therapeutics stock market strength indicators, traders can identify Compass Therapeutics entry and exit signals to maximize returns
Compass Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Compass Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Compass Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Compass to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0513 | |||
| Jensen Alpha | 0.0457 | |||
| Total Risk Alpha | (0.48) | |||
| Sortino Ratio | 0.034 | |||
| Treynor Ratio | 0.1374 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Compass Stock Analysis
When running Compass Therapeutics' price analysis, check to measure Compass Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Therapeutics is operating at the current time. Most of Compass Therapeutics' value examination focuses on studying past and present price action to predict the probability of Compass Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Therapeutics' price. Additionally, you may evaluate how the addition of Compass Therapeutics to your portfolios can decrease your overall portfolio volatility.